Home › Funds › Two Sigma Investments › CAPR
Two Sigma Investments position in CAPR
CAPRICOR THERAPEUTICS INC · Health Care
Latest position (Q1 2026)30.93K sh
Reported value held$940.33K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 19.70K | $96.33K | New |
| Q1 2024 | 24.00K | $162.96K | Add |
| Q2 2024 | 23.91K | $114.06K | Hold |
| Q3 2024 | 36.79K | $559.62K | Add |
| Q4 2024 | 119.05K | $1.64M | Add |
| Q1 2025 | 124.95K | $1.19M | Add |
| Q2 2025 | 155.84K | $1.55M | Add |
| Q3 2025 | 355.80K | $2.57M | Add |
| Q4 2025 | 54.77K | $1.58M | Reduce |
| Q1 2026 | 30.93K | $940.33K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CAPR
- BlackRock Inc 4.15M sh · $99.81M · Q2 2026
- Vanguard Group 2.56M sh · $73.94M · Q4 2025
- Goldman Sachs Group 1.58M sh · $38.00M · Q2 2026
- Citadel Advisors 1.55M sh · $37.23M · Q2 2026
- Geode Capital Management 1.37M sh · $33.05M · Q2 2026
- Fidelity Management & Research (FMR) 1.14M sh · $27.40M · Q2 2026
- Morgan Stanley 684.51K sh · $16.48M · Q2 2026
- UBS Group AG 619.66K sh · $14.92M · Q2 2026
- Northern Trust Corp 503.53K sh · $12.13M · Q2 2026
- Balyasny Asset Management 486.84K sh · $11.72M · Q2 2026
- D. E. Shaw & Co 438.75K sh · $10.57M · Q2 2026
- Millennium Management 402.23K sh · $9.69M · Q2 2026